Evidence map›Paper›PMID 35850210›Full record

ArticleThe Journal of investigative dermatology2022

Eukaryotic Elongation Factor 2 Kinase Activity Is Required for the Phenotypes of the Rpl24

John R P Knight, Christopher G Proud, Giovanna Mallucci, Tobias von der Haar, C Mark Smales, Anne E Willis, Owen J Sansom

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of investigative dermatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

John R P KnightBeatson Institute, Cancer Research UK, Glasgow, United Kingdom; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
Christopher G ProudLifelong Health, South Australian Health and Medical Research Institute, Adelaide, Australia; Department of Biological Sciences, University of Adelaide, Adelaide, Australia.
Giovanna MallucciUK Dementia Research Institute at The University of Cambridge, Cambridge, United Kingdom; Department of Clinical Neurosciences, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
Tobias von der HaarSchool of Biosciences, University of Kent, Canterbury, United Kingdom.
C Mark SmalesSchool of Biosciences, University of Kent, Canterbury, United Kingdom.
Anne E WillisMRC Toxicology Unit, University of Cambridge, Cambridge, United Kingdom.
Owen J SansomBeatson Institute, Cancer Research UK, Glasgow, United Kingdom; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom. Electronic address: o.sansom@beatson.gla.ac.uk.

Funding

Cancer Research UK A17196Cancer Research UK A21139Cancer Research UK A24388Cancer Research UK A31287Medical Research Council MC_UU_00025/7Wellcome Trust
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Elongation Factor 2 KinaseSignal TransductionAnimalsMicePhenotypePhosphorylationRibosomal ProteinsElongation Factor 2 Kinaseribosomal protein L24Ribosomal Proteins

Identifiers

PMID35850210
PMCPMC9708116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.